miR-31 Functions as an Oncomir Which Promotes Epithelial-Mesenchymal Transition via Regulating BAP1 in Cervical Cancer

BAP1 suppresses lung cancer progression and is inhibited by miR-31

(2016) Mengchao Yu et al.   Oncotarget

microRNA expression profiling identifies a four microRNA signature as a novel diagnostic and prognostic biomarker in triple negative breast cancers

(2015) Pierluigi Gasparini et al.   Oncotarget

MiR-489 regulates chemoresistance in breast cancer via epithelial mesenchymal transition pathway

(2014) Li Jiang et al.   FEBS LETTERS

MiR-31 is an independent prognostic factor and functions as an oncomir in cervical cancer via targeting ARID1A

(2014) Nan Wang et al.   GYNECOLOGIC ONCOLOGY

MicroRNAs in cancer: biomarkers, functions and therapy

(2014) Josie Hayes et al.   TRENDS IN MOLECULAR MEDICINE

Decreased expression of microRNA-31 associates with aggressive tumor progression and poor prognosis in patients with bladder cancer

(2013) S. Wang et al.   Clinical & Translational Oncology

MicroRNA-31 Predicts the Presence of Lymph Node Metastases and Survival in Patients with Lung Adenocarcinoma

(2013) W. Meng et al.   CLINICAL CANCER RESEARCH

MicroRNA-216a/217-induced epithelial-mesenchymal transition targets PTEN and SMAD7 to promote drug resistance and recurrence of liver cancer

(2013) Hongping Xia et al.   HEPATOLOGY

MicroRNA-31 Activates the RAS Pathway and Functions as an Oncogenic MicroRNA in Human Colorectal Cancer by Repressing RAS p21 GTPase Activating Protein 1 (RASA1)

(2013) Defang Sun et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Emerging targets in pancreatic cancer: epithelial–mesenchymal transition and cancer stem cells

(2013) Nagaraj Nagathihalli et al.   OncoTargets and Therapy

Epigenetic Repression of miR-31 Disrupts Androgen Receptor Homeostasis and Contributes to Prostate Cancer Progression

(2012) P.-C. Lin et al.   CANCER RESEARCH

MicroRNAs: critical regulators of epithelial to mesenchymal (EMT) and mesenchymal to epithelial transition (MET) in cancer progression

(2011) Marc D. Bullock et al.   BIOLOGY OF THE CELL

Global cancer statistics

(2011) Ahmedin Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Germline mutations in BAP1 predispose to melanocytic tumors

(2011) Thomas Wiesner et al.   NATURE GENETICS

miR-31 Ablates Expression of the HIF Regulatory Factor FIH to Activate the HIF Pathway in Head and Neck Carcinoma

(2010) C.-J. Liu et al.   CANCER RESEARCH

miR-21 and miR-31 Converge on TIAM1 to Regulate Migration and Invasion of Colon Carcinoma Cells

(2010) Charisa L. Cottonham et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

MicroRNA-31 functions as an oncogenic microRNA in mouse and human lung cancer cells by repressing specific tumor suppressors

(2010) Xi Liu et al.   JOURNAL OF CLINICAL INVESTIGATION

Microprocessor of microRNAs: regulation and potential for therapeutic intervention

(2010) Kevin J Beezhold et al.   Molecular Cancer

Frequent Mutation of BAP1 in Metastasizing Uveal Melanomas

(2010) J. W. Harbour et al.   SCIENCE

MicroRNAs and Cancer: Short RNAs Go a Long Way

(2009) Andrea Ventura et al.   CELL

RETRACTED: A Pleiotropically Acting MicroRNA, miR-31, Inhibits Breast Cancer Metastasis

(2009) Scott Valastyan et al.   CELL

Epithelial-Mesenchymal Transitions in Development and Disease

(2009) Jean Paul Thiery et al.   CELL

BRCA1-Associated Protein-1 Is a Tumor Suppressor that Requires Deubiquitinating Activity and Nuclear Localization

(2008) K. H. Ventii et al.   CANCER RESEARCH

BRCA1-Associated Protein 1 Interferes with BRCA1/BARD1 RING Heterodimer Activity

(2008) H. Nishikawa et al.   CANCER RESEARCH